Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Daniel Killeen, MD

Daniel Killeen, MD

  • Specialty: Otolaryngology-Otology, Otolaryngology-General
  • Location:
    University Hospitals
    395 E Market St
    Akron, OH 44304

Biography: Daniel Killeen, MD

Expertise

  • Acoustic Neuromas
  • Adult and Pediatric Hearing Loss
  • Cancer of the Ear
  • Chronic Otitis Media and Cholesteatoma
  • Cochlear Implants
  • Implantable Hearing Devices
  • Lateral Skull Based Surgery
  • Neurofibromatosis Type II
  • Otosclerosis
  • Paragangliomas
  • Surgical Restoration of Hearing Loss
  • Tympanic Membrane Repair (Tympanoplasty)
  • Vestibular Causes of Dizziness
  • Vestibular Schwannoma

Certifications & Memberships

  • Neurotology - American Board of Otolaryngology - Head and Neck Surgery
  • Otolaryngology - Head and Neck Surgery - American Board of Otolaryngology - Head and Neck Surgery

Education

Fellowship | Otology and Neurotology
Otology and Neurotology - University Of Texas Southwestern Medical Center (2019 - 2021)

Residency | Otolaryngology-Head and Neck Surgery
Otolaryngology-Head and Neck Surgery - University Of Texas Southwestern Medical Center (2014 - 2019)

Medical Education
Harvard Medical School (2014)

Undergraduate
Harvard University (2010)

About

Daniel Killeen, MD, specializes in neurotology/otology and skull base surgery, including medical and surgical treatment of diseases and tumors of the ear and lateral skull base, as well as hearing and vestibular disorders at University Hospitals in the Department of Otolaryngology – Head and Neck Surgery. He has an Assistant Professor appointment with Case Western Reserve University Medical School. Dr. Killeen is dual board certified in otolaryngology/head and neck surgery, and neurotology and otology (adult and pediatric). He is a Fellow of both the American Academy of Otolaryngology-Head and Neck Surgery and the American Neurotologic Society.

Dr. Killeen has expertise in endoscopic ear surgery. In addition to performing surgical approaches for lateral skull base tumors such as acoustic neuromas/vestibular schwannomas, he also has training in Gamma Knife radiosurgery for lateral skull base lesions. Dr. Killeen’s clinical interests include: acoustic neuroma/vestibular schwannoma treatment, both microsurgical resection and radiosurgery; endoscopic ear surgery for surgical treatment of hearing disorders such as stapedotomy for otosclerosis; cochlear implantation; treatment of chronic ear disease; and skull base surgery including surgical treatment of tumors of the ear.

Daniel Killeen is a graduate of Harvard University, obtaining a Bachelor of Arts in Molecular and Cellular Biology (cum laude with departmental high honors), and then earned his Doctorate of Medicine at Harvard Medical School. Dr. Killeen subsequently completed an otolaryngology residency at UT Southwestern Medical Center, followed by a fellowship in neurotology at UT Southwestern Medical Center. He joins UH most recently from the University of Alabama at Birmingham, where he served as an Assistant Professor and the Director of Endoscopic Ear Surgery.

Dr. Killeen has authored numerous publications in peer-reviewed journals and has given multiple presentations at national scientific meetings on topics in otology and neurotology. His research interests include endoscopic ear surgery as well as the natural history and treatment of acoustic neuromas/vestibular schwannomas, with a particular interest in developing new medical treatments for vestibular schwannomas.

Outside of work, Dr. Killeen enjoys skiing, traveling, and trying new foods and recipes with his wife.

Featured Videos

Watch to find out more about this University Hospitals provider.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Daniel Killeen did not disclose any Outside Relationships with Industry.